
16/09/2025
In a world-first medical achievement, Chinese researchers have reversed both Type 1 and Type 2 diabetes in humans using stem cell therapy. This milestone could free millions from daily insulin injections and lifelong medication.
The therapy works by reprogramming stem cells into insulin-producing pancreatic cells. Once transplanted, these cells restore the body’s ability to regulate blood sugar naturally. Unlike conventional treatments that only manage symptoms, this approach addresses the root cause of diabetes.
Early trials showed patients achieving stable blood sugar levels without external insulin for months. Some participants maintained normal glucose regulation long after treatment, raising hopes for a permanent cure.
This discovery positions China as a leader in regenerative medicine. If validated globally, stem cell therapy could transform diabetes care, potentially ending one of the most widespread chronic diseases in history.